2. Signaling Pathways
  3. Neuronal Signaling
  4. Huntingtin
  5. Huntingtin Inhibitor

Huntingtin Inhibitor

Huntingtin Inhibitors (5):

Cat. No. Product Name Effect Purity
  • HY-16009
    Buntanetap
    		Inhibitor 98.11%
    Buntanetap ((+)-Phenserine) is a multiple neurotoxic protein translation inhibitor with oral activity, including amyloid precursor protein (APP), α-synuclein (αSYN) and huntingtin protein (HTT). Buntanetap has anti-inflammatory effects and can be used in the study of Alzheimer's disease and Parkinson's disease.
  • HY-150236
    FITC-labeled Tominersen sodium
    		Inhibitor
    FITC-labeled Tominersen (sodium) is the Tominersen labeled with FITC. Tominersen (RG6042) is a second-generation 2′-O-(2-methoxyethyl) antisense oligonucleotide that targets huntingtin protein (HTT) mRNA and potently suppresses HTT production. Tominersen improves survival and reduces brain atrophy in mice. Tominersen can be used for the research of Huntington’s disease (HD).
  • HY-132594A
    Lexanersen sodium
    		Inhibitor
    Lexanersen sodium is an antisense oligonucleotide used for the study of Huntington's disease.
  • HY-150245
    mHTT-IN-1
    		Inhibitor
    mHTT-IN-1 (Example 1) is a potent mutant huntingtin (mHTT) inhibitor. mHTT is toxic and a major cause of the inherited autosomal dominant neurodegenerative disorder, Huntington's disease (HD). mHTT-IN-1 conducts the reduction of mHTT with an EC50 value of 46 nM.
  • HY-156103
    mHTT-IN-2
    		Inhibitor
    mHTT-IN-2 (compound 27) is a potent inhibitor (EC50=0.066 μM) of mutant huntingtin (mHTT). mHTT-IN-2 reduces canonical splicing of HTT RNA exons [49-50] and is a splicing regulator of the huntingtin (HTT) gene. mHTT-IN-2 exhibits inhibitory activity in vitro and in vivo in human HD stem cells and mouse BACHD models. mHTT-IN-2 may be used in the study of branaplam-related peripheral neuropathy.